These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1004 related items for PubMed ID: 31181779
1. A Ferulic Acid Derivative FXS-3 Inhibits Proliferation and Metastasis of Human Lung Cancer A549 Cells via Positive JNK Signaling Pathway and Negative ERK/p38, AKT/mTOR and MEK/ERK Signaling Pathways. Yue SJ, Zhang PX, Zhu Y, Li NG, Chen YY, Li JJ, Zhang S, Jin RY, Yan H, Shi XQ, Tang YP, Duan JA. Molecules; 2019 Jun 08; 24(11):. PubMed ID: 31181779 [Abstract] [Full Text] [Related]
2. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways. Chen Y, Zheng L, Liu J, Zhou Z, Cao X, Lv X, Chen F. Int Immunopharmacol; 2014 Aug 08; 21(2):447-55. PubMed ID: 24905636 [Abstract] [Full Text] [Related]
3. Huachansu Capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway. Ni T, Wang H, Li D, Tao L, Lv M, Jin F, Wang W, Feng J, Qian Y, Sunagawa M, Liu Y. Biomed Pharmacother; 2019 Oct 08; 118():109241. PubMed ID: 31351435 [Abstract] [Full Text] [Related]
4. SSPH I, A Novel Anti-cancer Saponin, Inhibits EMT and Invasion and Migration of NSCLC by Suppressing MAPK/ERK1/2 and PI3K/AKT/ mTOR Signaling Pathways. Zhou J, Luo J, Gan R, Zhi L, Zhou H, Lv M, Huang Y, Liang G. Recent Pat Anticancer Drug Discov; 2024 Oct 08; 19(4):543-555. PubMed ID: 38305308 [Abstract] [Full Text] [Related]
5. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways. Chun J, Kim YS. Chem Biol Interact; 2013 Oct 05; 205(3):212-21. PubMed ID: 23867902 [Abstract] [Full Text] [Related]
6. Salidroside represses proliferation, migration and invasion of human lung cancer cells through AKT and MEK/ERK signal pathway. Ren M, Xu W, Xu T. Artif Cells Nanomed Biotechnol; 2019 Dec 05; 47(1):1014-1021. PubMed ID: 30880481 [Abstract] [Full Text] [Related]
7. Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK-JNK-mediated AKT/mTOR signaling pathway. You S, Li W, Guan Y. Mol Med Rep; 2018 Mar 05; 17(3):4203-4212. PubMed ID: 29344654 [Abstract] [Full Text] [Related]
8. Angelicin inhibits human lung carcinoma A549 cell growth and migration through regulating JNK and ERK pathways. Li G, He Y, Yao J, Huang C, Song X, Deng Y, Xie S, Ren J, Jin M, Liu H. Oncol Rep; 2016 Dec 05; 36(6):3504-3512. PubMed ID: 27748898 [Abstract] [Full Text] [Related]
9. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways. Jiang M, Zhou LY, Xu N, An Q. Thorac Cancer; 2019 Jun 05; 10(6):1319-1333. PubMed ID: 31055884 [Abstract] [Full Text] [Related]
10. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. Li JP, Yang YX, Liu QL, Pan ST, He ZX, Zhang X, Yang T, Chen XW, Wang D, Qiu JX, Zhou SF. Drug Des Devel Ther; 2015 Jun 05; 9():1627-52. PubMed ID: 25834401 [Abstract] [Full Text] [Related]
11. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway. Shi H, Pu J, Zhou XL, Ning YY, Bai C. Tumour Biol; 2017 May 05; 39(5):1010428317697568. PubMed ID: 28459375 [Abstract] [Full Text] [Related]
12. Zeylenone, a naturally occurring cyclohexene oxide, inhibits proliferation and induces apoptosis in cervical carcinoma cells via PI3K/AKT/mTOR and MAPK/ERK pathways. Zhang L, Huo X, Liao Y, Yang F, Gao L, Cao L. Sci Rep; 2017 May 10; 7(1):1669. PubMed ID: 28490807 [Abstract] [Full Text] [Related]
13. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells. Pan ST, Qin Y, Zhou ZW, He ZX, Zhang X, Yang T, Yang YX, Wang D, Qiu JX, Zhou SF. Drug Des Devel Ther; 2015 May 10; 9():1601-26. PubMed ID: 25834400 [Abstract] [Full Text] [Related]
14. Luteolin exerts pro-apoptotic effect and anti-migration effects on A549 lung adenocarcinoma cells through the activation of MEK/ERK signaling pathway. Meng G, Chai K, Li X, Zhu Y, Huang W. Chem Biol Interact; 2016 Sep 25; 257():26-34. PubMed ID: 27474067 [Abstract] [Full Text] [Related]
15. Transmembrane-4 L-six family member-1 (TM4SF1) promotes non-small cell lung cancer proliferation, invasion and chemo-resistance through regulating the DDR1/Akt/ERK-mTOR axis. Ye L, Pu C, Tang J, Wang Y, Wang C, Qiu Z, Xiang T, Zhang Y, Peng W. Respir Res; 2019 May 29; 20(1):106. PubMed ID: 31142317 [Abstract] [Full Text] [Related]
16. Fucoxanthin Activates Apoptosis via Inhibition of PI3K/Akt/mTOR Pathway and Suppresses Invasion and Migration by Restriction of p38-MMP-2/9 Pathway in Human Glioblastoma Cells. Liu Y, Zheng J, Zhang Y, Wang Z, Yang Y, Bai M, Dai Y. Neurochem Res; 2016 Oct 29; 41(10):2728-2751. PubMed ID: 27394418 [Abstract] [Full Text] [Related]
17. UNBS5162 as a novel naphthalimide holds efficacy in human gastric carcinoma cell behaviors mediated by AKT/ERK signaling pathway. Li HH, Song XX, Liu B, Yang WP. Drug Dev Ind Pharm; 2019 Aug 29; 45(8):1306-1312. PubMed ID: 30995142 [Abstract] [Full Text] [Related]
18. The novel PI3K inhibitor S1 synergizes with sorafenib in non-small cell lung cancer cells involving the Akt-S6 signaling. Wang J, Ma S, Chen X, Zhang S, Wang Z, Mei Q. Invest New Drugs; 2019 Oct 29; 37(5):828-836. PubMed ID: 30456603 [Abstract] [Full Text] [Related]
19. Xiaoai Jiedu Recipe Inhibits Proliferation and Metastasis of Non-Small Cell Lung Cancer Cells by Blocking the P38 Mitogen-Activated Protein Kinase (MAPK) Pathway. Wang Y, Xu C, Xu B, Li L, Li W, Wang W, Wu M. Med Sci Monit; 2019 Oct 07; 25():7538-7546. PubMed ID: 31590176 [Abstract] [Full Text] [Related]
20. Blockage of PAK1 alleviates the proliferation and invasion of NSCLC cells via inhibiting ERK and AKT signaling activity. Song P, Song B, Liu J, Wang X, Nan X, Wang J. Clin Transl Oncol; 2021 Apr 07; 23(4):892-901. PubMed ID: 32974862 [Abstract] [Full Text] [Related] Page: [Next] [New Search]